skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,688  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Aged remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration
Material Type:
Article
Add to My Research

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration

Journal of clinical oncology, 2020-11, Vol.38 (32), p.3763-3772 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.01035 ;PMID: 32795228

Full text available

2
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects
Material Type:
Article
Add to My Research

Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects

Journal of allergy and clinical immunology, 2018-12 [Peer Reviewed Journal]

info:eu-repo/semantics/openAccess ;ISSN: 0091-6749 ;EISSN: 1097-6825 ;DOI: 10.1016/j.jaci.2018.02.055

Digital Resources/Online E-Resources

3
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Material Type:
Article
Add to My Research

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

The New England journal of medicine, 2018-12, Vol.379 (24), p.2342-2350 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1809697 ;PMID: 30280658

Full text available

4
Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial
Material Type:
Article
Add to My Research

Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial

The Lancet infectious diseases, 2019-01, Vol.19 (1), p.35-45 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 2019 ;ISSN: 1473-3099 ;ISSN: 1474-4457 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(18)30482-1 ;PMID: 30292481

Full text available

5
Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis
Material Type:
Article
Add to My Research

Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis

European journal of vascular and endovascular surgery, 2021, Vol.61 (1), p.9 [Peer Reviewed Journal]

ISSN: 1532-2165 ;EISSN: 1532-2165 ;DOI: 10.1016/j.ejvs.2020.09.023

Digital Resources/Online E-Resources

6
Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19
Material Type:
Article
Add to My Research

Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19

The Journal of experimental medicine, 2020-12, Vol.217 (12) [Peer Reviewed Journal]

2020 Radermecker et al. ;2020 Radermecker et al. 2020 ;ISSN: 0022-1007 ;ISSN: 1540-9538 ;EISSN: 1540-9538 ;DOI: 10.1084/jem.20201012 ;PMID: 32926097

Full text available

7
Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study
Material Type:
Article
Add to My Research

Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study

Lancet neurology, 2019-10, Vol.18 (10), p.923-934 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 1474-4422 ;ISSN: 1474-4465 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(19)30232-7 ;PMID: 31526754

Full text available

8
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer
Material Type:
Article
Add to My Research

Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer

The New England journal of medicine, 2020-02, Vol.382 (6), p.514-524 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1911149 ;PMID: 31826360

Full text available

9
Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis
Material Type:
Article
Add to My Research

Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis

PloS one, 2017-01, Vol.12 (1), p.e0169548-e0169548 [Peer Reviewed Journal]

COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Beaudart et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Beaudart et al 2017 Beaudart et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0169548 ;PMID: 28095426

Full text available

10
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Material Type:
Article
Add to My Research

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

The Lancet (British edition), 2018-11, Vol.392 (10159), p.1789-1858 [Peer Reviewed Journal]

2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2018. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;info:eu-repo/semantics/openAccess ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2018 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32279-7 ;PMID: 30496104

Full text available

11
Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review of systematic reviews and meta-analyses
Material Type:
Article
Add to My Research

Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review of systematic reviews and meta-analyses

Nutrition reviews, 2021-01, Vol.79 (2), p.121-147 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0029-6643 ;EISSN: 1753-4887 ;DOI: 10.1093/nutrit/nuaa011 ;PMID: 32483625

Full text available

12
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
Material Type:
Article
Add to My Research

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

The Lancet (British edition), 2018-11, Vol.392 (10159), p.1736-1788 [Peer Reviewed Journal]

2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2018. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;info:eu-repo/semantics/openAccess ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/). https://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2018 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;ISSN: 2214-109X ;EISSN: 1474-547X ;EISSN: 2214-109X ;DOI: 10.1016/S0140-6736(18)32203-7 ;PMID: 30496103

Full text available

13
Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial
Material Type:
Article
Add to My Research

Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

Journal of clinical oncology, 2016-03, Vol.34 (9), p.972-979 [Peer Reviewed Journal]

2016 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;ISSN: 1527-7755 ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2015.64.0060 ;PMID: 26811524

Full text available

14
Ageism and COVID-19: what does our society’s response say about us?
Material Type:
Article
Add to My Research

Ageism and COVID-19: what does our society’s response say about us?

Age and Ageing, 2020-08, Vol.49 (5), p.692-695 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://academic.oup.com/journals/pages/coronavirus . ;The Author(s) 2020. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0002-0729 ;ISSN: 1468-2834 ;EISSN: 1468-2834 ;DOI: 10.1093/ageing/afaa097 ;PMID: 32377666

Digital Resources/Online E-Resources

15
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Material Type:
Article
Add to My Research

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

The Lancet (British edition), 2018-11, Vol.392 (10159), p.1923-1994 [Peer Reviewed Journal]

2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2018. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.. ;info:eu-repo/semantics/openAccess ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/). https://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. 2018 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32225-6 ;PMID: 30496105

Full text available

16
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial
Material Type:
Article
Add to My Research

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

The Lancet (British edition), 2019-10, Vol.394 (10206), p.1325-1334 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31997-X ;PMID: 31488373

Full text available

17
Evidence for the Domains Supporting the Construct of Intrinsic Capacity
Material Type:
Article
Add to My Research

Evidence for the Domains Supporting the Construct of Intrinsic Capacity

The journals of gerontology. Series A, Biological sciences and medical sciences, 2018-11, Vol.73 (12), p.1653-1660 [Peer Reviewed Journal]

Copyright Oxford University Press Dec 2018 ;ISSN: 1079-5006 ;ISSN: 1758-535X ;EISSN: 1758-535X ;DOI: 10.1093/gerona/gly011 ;PMID: 29408961

Full text available

18
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Material Type:
Article
Add to My Research

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

The New England journal of medicine, 2016-12, Vol.375 (22), p.2154-2164 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1611310 ;PMID: 27717299

Full text available

19
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Material Type:
Article
Add to My Research

Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Lancet, 2018-11, Vol.392 (10159), p.1859-1922 [Peer Reviewed Journal]

2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2018. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;info:eu-repo/semantics/openAccess ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/). https://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32335-3 ;PMID: 30415748

Full text available

20
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Material Type:
Article
Add to My Research

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

The New England journal of medicine, 2021-04, Vol.384 (14), p.1289-1300 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2035716 ;PMID: 33616314

Full text available

Results 1 - 20 of 1,688  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (1,677)

Refine My Results

Creation Date 

From To
  1. Before 1986  (27)
  2. 1986 To 1994  (82)
  3. 1995 To 2003  (305)
  4. 2004 To 2013  (644)
  5. After 2013  (631)
  6. More options open sub menu

Resource Type 

  1. Articles  (1,566)
  2. Web Resources  (122)
  3. More options open sub menu

Language 

  1. English  (1,569)
  2. Japanese  (293)
  3. French  (121)
  4. Norwegian  (12)
  5. Portuguese  (2)
  6. Russian  (2)
  7. German  (1)
  8. More options open sub menu

Searching Remote Databases, Please Wait